SHOULD DOPAMINE AGONISTS BE GIVEN EARLY OR LATE IN THE TREATMENT OF PARKINSONS-DISEASE

被引：38

作者：

RASCOL, A ^{[1
]}

MONTASTRUC, JL ^{[1
]}

RASCOL, O ^{[1
]}

机构：

[1] CHU PURPAN,DEPT MED & CLIN PHARMACOL,F-31059 TOULOUSE,FRANCE

来源：

关键词：

D O I：

10.1017/S0317167100046461

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：229 / 232

页数：4

共 8 条

[1] CALNE DB, 1983, LISURIDE OTHER DOPAM, V1, P576
[2] GOLDSTEIN M, 1980, ADV BIOCH PSYCHOPHAR, V23, P413
[3] HOEHN MM, 1967, NEUROLOGY, V17, P952
[4] MULTIPLE RECEPTORS FOR DOPAMINE
KEBABIAN, JW
CALNE, DB
[J]. NATURE, 1979, 277 (5692) : 93 - 96
[5] SUSTAINED BROMOCRIPTINE THERAPY IN PREVIOUSLY UNTREATED PATIENTS WITH PARKINSONS-DISEASE
LEES, AJ
STERN, GM
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1981, 44 (11) : 1020 - 1023
[6] RASCOL A, 1982, REV NEUROL, V138, P401
[7] LONG-TERM TREATMENT OF PARKINSONS-DISEASE WITH BROMOCRIPTINE
RASCOL, A
GUIRAUD, B
MONTASTRUC, JL
DAVID, J
CLANET, M
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1979, 42 (02) : 143 - 150
[8] TEYCHENNE PF, 1981, RES CLIN FORUMS, V3, P37